Thor Medical ASA (LTS:0R6Y) ROE % Adjusted to Book Value : 0.00% (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Thor Medical ASA ROE % Adjusted to Book Value?

Thor Medical ASA's ROE % for the quarter that ended in Dec. 2023 was 0.00%. Thor Medical ASA's PB Ratio for the quarter that ended in Dec. 2023 was 1.14. Thor Medical ASA's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was 0.00%.

Thor Medical ASA ROE % Adjusted to Book Value Historical Data

The historical data trend for Thor Medical ASA's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thor Medical ASA ROE % Adjusted to Book Value Chart

Thor Medical ASA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-21.30

-17.30

-143.68

-13.88

Thor Medical ASA Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22	Jun23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-31.93	-92.36	-	-	-

Competitive Comparison of Thor Medical ASA's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Thor Medical ASA's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Thor Medical ASA's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Thor Medical ASA's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Thor Medical ASA's ROE % Adjusted to Book Value falls into.

Thor Medical ASA ROE % Adjusted to Book Value Calculation

Thor Medical ASA's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-15.82%	/	1.14
	=	-13.88%

Thor Medical ASA's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	1.14
	=	0.00%

Thor Medical ASA ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Thor Medical ASA's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Thor Medical ASA (LTS:0R6Y) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Thor Medical ASA (LTS:0R6Y) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

TRMED:Norway 8NN:Germany

Address

Kjelsasveien 168 B, Oslo, NOR, 0884

Website

https://www.nordicnanovector.com

Nordic Nanovector ASA is a biopharmaceutical company. It is engaged in the development and commercialization of targeted therapeutics to improve the lives of patients with haematological cancers, such as non-Hodgkin lymphoma and leukaemia. The company's main clinical stage product is Betalutin.

Thor Medical ASA (LTS:0R6Y) Headlines

No Headlines